欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号FR/H/0278/001
药品名称Remodulin 1 mg/ml
活性成分
    • treprostinil sodium salt 1.0 mg/ml
剂型Solution for infusion
上市许可持有人Ferrer Internacional, S.A. Gran Via Carlos III, 94 Barcelona 08028 Spain
参考成员国 - 产品名称France (FR)
互认成员国 - 产品名称
    • Germany (DE)
    • Denmark (DK)
    • Belgium (BE)
    • Netherlands (NL)
    • Luxembourg (LU)
    • Iceland (IS)
    • Austria (AT)
      REMODULIN 1 mg/ml Infusionslösung
    • Portugal (PT)
    • Italy (IT)
    • Greece (GR)
    • Sweden (SE)
    • Norway (NO)
    • Finland (FI)
    • Poland (PL)
      Remodulin
    • Latvia (LV)
    • Lithuania (LT)
      REMODULIN 1 mg/ml infuzinis tirpalas
    • Estonia (EE)
    • Hungary (HU)
    • Cyprus (CY)
    • Czechia (CZ)
    • Slovakia (SK)
    • Slovenia (SI)
许可日期2005/08/10
最近更新日期2024/05/14
药物ATC编码
    • B01AC21 treprostinil
申请类型
  • TypeLevel1：New Active Substance
  • TypeLevel2：Initial Application
  • TypeLevel3：Full Dossier [Article 8.3(i)]
  • TypeLevel4：Chemical Substance
  • TypeLevel5：Prescription Only
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase